CoChat
Cited by 2,464

The DOI matches its Crossref record; 430 of the 430 references it cites were found in a registry or an index.

Nicotine replacement therapy for smoking cessation

Open access
Stead, Lindsay F, Perera, Rafael, Bullen, Chris, Mant, David, Hartmann-Boyce, Jamie, Cahill, Kate, Lancaster, Tim · 2012 · Cochrane Database of Systematic Reviews

Abstract

BACKGROUND: The aim of nicotine replacement therapy (NRT) is to temporarily replace much of the nicotine from cigarettes to reduce motivation to smoke and nicotine withdrawal symptoms, thus easing the transition from cigarette smoking to complete abstinence. OBJECTIVES: The aims of this review were: To determine the effect of NRT compared to placebo in aiding smoking cessation, and to consider whether there is a difference in effect for the different forms of NRT (chewing gum, transdermal patches, oral and nasal sprays, inhalers and tablets/lozenges) in achieving abstinence from cigarettes. To determine whether the effect is influenced by the dosage, form and timing of use of NRT; the intensity of additional advice and support offered to the smoker; or the clinical setting in which the smoker is recruited and treated. To determine whether combinations of NRT are more likely to lead to successful quitting than one type alone. To determine whether NRT is more or less likely to lead to successful quitting compared to other pharmacotherapies. SEARCH METHODS: We searched the Cochrane Tobacco Addiction Group trials register for papers mentioning 'NRT' or any type of nicotine replacement therapy in the title, abstract or keywords. Date of most recent search July 2012. SELECTION CRITERIA: Randomized trials in which NRT was compared to placebo or to no treatment, or where different doses of NRT were compared. We excluded trials which did not report cessation rates, and those with follow-up of less than six months. DATA COLLECTION AND ANALYSIS: We extracted data in duplicate on the type of participants, the dose, duration and form of nicotine therapy, the outcome measures, method of randomization, and completeness of follow-up. The main outcome measure was abstinence from smoking after at least six months of follow-up. We used the most rigorous definition of abstinence for each trial, and biochemically validated rates if available. We calculated the risk ratio (RR) for each study. Where appropriate, we performed meta-analysis using a Mantel-Haenszel fixed-effect model. MAIN RESULTS: We identified 150 trials; 117 with over 50,000 participants contributed to the primary comparison between any type of NRT and a placebo or non-NRT control group. The risk ratio (RR) of abstinence for any form of NRT relative to control was 1.60 (95% confidence interval [CI] 1.53 to 1.68). The pooled RRs for each type were 1.49 (95% CI 1.40 to 1.60, 55 trials) for nicotine gum; 1.64 (95% CI 1.52 to 1.78, 43 trials) for nicotine patch; 1.95 (95% CI 1.61 to 2.36, 6 trials) for oral tablets/lozenges; 1.90 (95% CI 1.36 to 2.67, 4 trials) for nicotine inhaler; and 2.02 (95% CI 1.49 to 2.73, 4 trials) for nicotine nasal spray. One trial of oral spray had an RR of 2.48 (95% CI 1.24 to 4.94). The effects were largely independent of the duration of therapy, the intensity of additional support provided or the setting in which the NRT was offered. The effect was similar in a small group of studies that aimed to assess use of NRT obtained without a prescription. In highly dependent smokers there was a significant benefit of 4 mg gum compared with 2 mg gum, but weaker evidence of a benefit from higher doses of patch. There was evidence that combining a nicotine patch with a rapid delivery form of NRT was more effective than a single type of NRT (RR 1.34, 95% CI 1.18 to 1.51, 9 trials). The RR for NRT used for a short period prior to the quit date was 1.18 (95% CI 0.98 to 1.40, 8 trials), just missing statistical significance, though the efficacy increased when we pooled only patch trials and when we removed one trial in which confounding was likely. Five studies directly compared NRT to a non-nicotine pharmacotherapy, bupropion; there was no evidence of a difference in efficacy (RR 1.01; 95% CI 0.87 to 1.18). A combination of NRT and bupropion was more effective than bupropion alone (RR 1.24; 95% CI 1.06 to 1.45, 4 trials). Adverse effects from using NRT are related to the type of product, and include skin irritation from patches and irritation to the inside of the mouth from gum and tablets. There is no evidence that NRT increases the risk of heart attacks. AUTHORS' CONCLUSIONS: All of the commercially available forms of NRT (gum, transdermal patch, nasal spray, inhaler and sublingual tablets/lozenges) can help people who make a quit attempt to increase their chances of successfully stopping smoking. NRTs increase the rate of quitting by 50 to 70%, regardless of setting. The effectiveness of NRT appears to be largely independent of the intensity of additional support provided to the individual. Provision of more intense levels of support, although beneficial in facilitating the likelihood of quitting, is not essential to the success of NRT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd000146.pub4

Cites

430 of 430 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Items 201–400 of 430

Research works printed but not linked: 66

  1. Blondal, 1993, Controlled trial of nicotine nasal spray as an aid to stopping smoking [abstract], European Respiratory Journal, 6, 631S
  2. Blondal T Ludviksdottir D Gudmundsson L Olafsdottir I Gustavsson G Westin A Efficacy of nicotine nasal spray added to transdermal nicotine patches in smoking cessation [Abstract] Proceedings of the 10th World Conference on Tobacco or Health; Aug 24-28; Beijing, China 1997 48
  3. Bohandana, 1999, Nicotine inhaler and nicotine patch: a combination therapy for smoking cessation [abstract], Nicotine & Tobacco Research, 1, 189
  4. Burton S Campbell IA Prescott RJ Nicotine patches versus placebo in 235 hospital patients [abstract 191] Abstracts from the 8th World Conference on Tobacco or Health, Mar 30-Apr 3; Buenos Aires, Argentina 1992
  5. Croghan, 1998, Comparison of a 15 mg transdermal nicotine patch alone versus nicotine nasal spray alone versus both for smoking cessation, Journal of Addictive Diseases, 17, 121
  6. Daughton, 1992, Effects of transdermal nicotine as an adjunct in smoking cessation therapy. A double-blind randomized study controlled with placebo [Italian], Archivio Monaldi, 47, 17
  7. Dautzenberg B Peiffer G Toulouse F Yvinec MJ Jacob N Kienzler JL Randomized trial assessment of nicotinell lozenge 1mg, a new oral nicotine replacement therapy Abstract Book. Society for Research on Nicotine and Tobacco 3rd European Conference, Paris 2001 55
  8. Dautzenberg, 2001, First demonstration of the good efficacy/safety ratio of Nicotinell® 1mg Lozenge (NL 1mg), a new form of nicotine substitution, by randomised clinical trial, European Respiratory Journal, 18 Suppl 33, 12s
  9. Abelin, 1991, Clinical experience with a transdermal nicotine system in healthy nicotine-dependent smokers, 35
  10. Abelin, 1989, Effectiveness of a transdermal nicotine system in smoking cessation studies, Methods and Findings in Experimental and Clinical Pharmacology, 11, 205
  11. Muller, 1990, The use of transdermal nicotine in smoking cessation, Lung, 168, 445, 10.1007/BF02718163 · DOI
  12. Fiore, 1994, Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments, Chest, 105, 524, 10.1378/chest.105.2.524 · DOI
  13. Quilez Garcia, 1993, Treatment for smoking with nicotine gum in primary care. A double blind trial [Spanish], Revista Clinica Espanol, 192, 157
  14. Glover E Glover P Franzon M Sullivan R Cerullo C Safety and efficacy of a nicotine sublingual tablet for smoking cessation [abstract] Smoke Free 21st Century, 2nd European Conference on Tobacco or Health; Las Palmas de Gran Canaria 1999
  15. Glover ED Franzon M Sullivan CR Cerullo CL A nicotine sublingual tablet for treating tobacco dependence [Abstract] Society for Research on Nicotine and Tobacco 3rd Europe Conference, Paris September 2001 Abstract Book 2001 48
  16. Glover ED Glover PN Franzon M Sullivan R Sullivan P Howell R A nicotine sublingual tablet for smoking cessation: 6-month data [Abstract] Proceedings of the 10th World Conference on Tobacco or Health; Aug 24-28 Beijing, China 1997
  17. Hays, 1997, Over-the-Counter (OTC) transdermal nicotine patch therapy [abstract], Journal of Addictive Diseases, 16, 136
  18. Hays JT Croghan IT Offord KP Hurt RD Schroeder DR Wolter TD Over the counter 22mg nicotine patch therapy for smoking cessation: results from randomized double-blind placebo-controlled and open label trials Abstract Book. Society for Research on Nicotine and Tobacco 5th Annual Meeting, San Diego (CA) 1999 · DOI
  19. Kornitzer, 1993, Efficiency and safety of combined use of nicotine patches and nicotine gum in smoking cessation: a placebo controlled double-blind trial [abstract], European Respiratory Journal, 6, 630S
  20. Kralikova, 2002, The clinical benefits of NRT-supported smoking reduction, Nicotine & Tobacco Research, 4, 243
  21. Leischow, 1996, Efficacy of the nicotine inhaler as an adjunct to smoking cessation, American Journal of Health Behavior, 20, 364
  22. Leischow SJ Ranger-Moore J Muramoto ML Matthews E The safety and effectiveness of the nicotine inhaler for smoking cessation in an over-the-counter setting (POS4-78) Abstract Book. Society for Research on Nicotine and Tobacco 9th Annual Meeting, New Orleans, LA 2003 100 · DOI
  23. Mori T Shimao T Yulchiro G Namiki M Hyachi T A clinical trial of nicotine chewing gum for smoking cessation [abstract 428] 8th World Conference on Tobacco or Health; Buenos Aires, Argentina 1992
  24. Nakamura M Saito J Oshima A Miyamoto M Matushita A Endo S Effect of nicotine chewing gun in smoking cessation classes The Global War. Proceedings of the 7th World Conference on Tobacco and Health; Perth, Western Australia Perth Health Department of Western Australia 1990 665 7
  25. Perng, 1999, Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation, American Journal of Respiratory and Critical Care Medicine, 159, A735
  26. Richmond RL Makinson RJ Giugni AA Webster IW General Practitioner smoking interventions in Australia: results of studies over the past ten years The Global War, Proceedings of the 7th World Conference on Tobacco and Health. Perth, Western Australia Perth Health Department of Western Australia 1990 657 60
  27. Rose, 1996, Nicotine/mecamylamine combination treatment for smoking cessation [published erratum appears in Drug Development Research 1997;40:215], Drug Development Research, 38, 243, 10.1002/(SICI)1098-2299(199607/08)38:3/4<243::AID-DDR13>3.0.CO;2-# · DOI
  28. Rose, 2011, Nicotine preloading: The importance of a pre-cessation reduction in smoking behavior, Psychopharmacology, 217, 453, 10.1007/s00213-011-2350-0 · DOI
  29. Roto, 1987, Nicotine gum and withdrawal from smoking, Suomen Laakarllehtl, 36, 3445
  30. Schneider, 1985, Nicotine gum vs. placebo gum: comparisons of withdrawal symptoms and success rates, NIDA Research Monograph, 53, 83
  31. Schneider, 1983, Nicotine gum in smoking cessation: a placebo-controlled, double-blind trial, Addictive Behaviors, 8, 253, 10.1016/0306-4603(83)90020-5 · DOI · Paper page
  32. Shiffman, 2002, Efficacy of a nicotine lozenge for smoking cessation, Archives of Internal Medicine, 162, 1267, 10.1001/archinte.162.11.1267 · DOI · Paper page
  33. Shiffman, 2009, Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial, American Journal of Preventive Medicine, 36, 96, 10.1016/j.amepre.2008.09.039 · DOI
  34. Mikkelsen, 1994, Three-year outcome of two- and three-year sustained abstainers from a smoking cessation study with nicotine patches, Journal of Smoking-Related Disorders, 5, 95
  35. Tonnesen, 1992, Two-year outcome in a smoking cessation trial with a nicotine patch, Journal of Smoking-Related Disorders, 3, 241
  36. Villa, 1999, Effectiveness of a multicomponent program to quit smoking with and without nicotine chewing gum [Spanish], Psicologia Conductual, 7, 107
  37. Pharmacia, 1998, Nicorette Nicotine Microtab Monograph, Adis Internatio
  38. Wallstrom M Nilsson F Hirsch JM A double-blind placebo controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation [abstract] European Respiratory Journal 1997 440S
  39. Bolliger, 2000, Practical experiences in smoking reduction and cessation, Addiction, 95, S19, 10.1046/j.1360-0443.95.1s1.2.x · DOI
  40. Bolliger, 2002, Influence of long-term smoking reduction on health risk markers and quality of life, Nicotine & Tobacco Research, 4, 433, 10.1080/1462220021000018380 · DOI
  41. Bolliger, 2000, Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety, BMJ, 321, 329, 10.1136/bmj.321.7257.329 · DOI · Paper page
  42. Brantmark, 1973, Nicotine-containing chewing gum as an anti-smoking aid, Psychopharmacologia, 31, 191, 10.1007/BF00422509 · DOI
  43. Croghan, 2005, Comparing nicotine inhaler, bupropion and nicotine inhaler plus bupropion in treating tobacco dependence [abstract], Nicotine & Tobacco Research, 7, 680
  44. Glover ED Glover PN Sullivan CR Sullivan P Nilsson F Sawe U Nicotine inhaler versus placebo in smoking cessation [abstract 237] Abstracts from the 8th World Conference on Tobacco or Health, Buenos Aires, Argentina 1992
  45. Haustein, 2003, The effect of short-term or long-term reduction on smoking cessation; results from a placebo controlled smoking reduction study with the nicotine gum, Nicotine & Tobacco Research, 5, 278
  46. Sonntag, 2003, Smoking cessation in primary care: implementation effectiveness and optimized allocation, Suchtmedizin in Forschung und Praxis, 5, 137
  47. Jarvik, 1984, Degree of addiction and effectiveness of nicotine gum therapy for smoking, American Journal of Psychiatry, 141, 790, 10.1176/ajp.141.6.790 · DOI
  48. Korberly B Gustavsson G Kruse E Over-the-counter efficacy of a 15 mg daytime nicotine patch for smoking cessation: a randomized multicenter trial Abstract book. Society for Research on Nicotine and Tobacco 4th European Conference October 3-5 Santander, Spain 2002 23
  49. Kozak, 1995, High-dose treatment with the nicotine patch, International Journal of Smoking Cessation, 4, 26
  50. Krumpe, 1989, Efficacy of transdermal nicotine administration as an adjunct for smoking cessation in heavily nicotine addicted smokers, Annual Review of Respiratory Disease, 139, A337
  51. Landfeldt, 1998, Nicotine replacement treatment in heavy smokers: nicotine nasal spray combined with nicotine patch in a double-blind controlled study (abstract), European Respiratory Journal, 12, 154S
  52. Meier Lammermann, 1990, Combination of transdermal nicotine substitution and behavioural group therapy in smoking cessation, European Respiratory Journal, 3, 168S
  53. Rennard, 2002, Efficacy of nicotine inhaler in smoking reduction, Nicotine & Tobacco Research, 4, 380
  54. Shiffman S Dresler CM Gorsline J Dimarino ME The efficacy of nicotine patch in an over-the-counter environment: results from a randomized, double-blind, placebo-controlled trial (PO130) Abstract book, 11th World Conference on Tobacco or Health, 6-11 August, Chicago, Illinois 2000
  55. Sutherland, 1999, A placebo-controlled double-blind combination trial of nicotine spray and patch [abstract], Nicotine & Tobacco Research, 1, 186
  56. Uyar, 2005, Comparison of nicotine patch and bupropion in treating tobacco dependence, European Respiratory Journal, 26, 388s
  57. Vikhireva O Shalnova S Deev A Nicotine replacement therapy in Russia: old wine in new skins? Randomized parallel study of nicotine gum/inhaler in smoking cessation/reduction Abstract book. Society for Research on Nicotine and Tobacco. Fifth European Conference. November 20-22nd, Padua, Italy 2003
  58. Wennike, 2003, Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up, Addiction, 98, 1395, 10.1046/j.1360-0443.2003.00489.x · DOI · Paper page
  59. Durcan, 2002, Impact of prior nicotine replacement therapy on smoking cessation efficacy, American Journal of Health Behaviors, 26, 213, 10.5993/AJHB.26.3.6 · DOI
  60. Fagerstrom, 2003, Clinical treatment of tobacco dependence: The endurance of pharmacologic efficacy, Journal of Clinical Psychiatry Monograph, 18, 35
  61. Osservatorio, 2004, Linee guida cliniche per promuovere la cessazione dell’abitudine al fumo
  62. Stead, 2002, Effectiveness of over-the-counter nicotine replacement therapy, JAMA, 288, 3109, 10.1001/jama.288.24.3109-JLT1225-1-4 · DOI
  63. Transdermal Nicotine Working Group, 1994, Nicotine replacement therapy for patients with coronary artery disease. Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease, Archives of Internal Medicine, 154, 989, 10.1001/archinte.1994.00420090063007 · doi:10.1001/archinte.1994.00420090063007
  64. Silagy, 1996, Nicotine replacement therapy for smoking cessation, Cochrane Database of Systematic Reviews
  65. Silagy, 2001, Nicotine replacement therapy for smoking cessation, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000146 · doi:10.1002/14651858.cd000146 · Paper page
  66. Silagy, 2002, Nicotine replacement therapy for smoking cessation, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000146 · doi:10.1002/14651858.cd000146 · Paper page

Cited by

See all 2,464

Metadata

Authors
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T.
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2012-11-14
Volume
11
Pages
CD000146-CD000146
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W1955803833
Cited by
2,464
References
430
FWCI
126.80
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.